{"id":"https://openalex.org/W7225340246","doi":"https://doi.org/10.21203/rs.3.rs-11399490/v1","title":"Serum nerve growth factor and early motor neuropathy in children receiving neurotoxic chemotherapy: a prospective single-center cohort study","display_name":"Serum nerve growth factor and early motor neuropathy in children receiving neurotoxic chemotherapy: a prospective single-center cohort study","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225340246","doi":"https://doi.org/10.21203/rs.3.rs-11399490/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-11399490/v1","doi":"https://doi.org/10.21203/rs.3.rs-11399490/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11399490/v1","pdf_url":"https://www.researchsquare.com/article/rs-11399490/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.researchsquare.com/article/rs-11399490/latest.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086483845","display_name":"\u0130rem T\u00dcRKO\u011eLU KUZU","orcid":"https://orcid.org/0000-0002-2398-8571","observed_orcids":["https://orcid.org/0000-0002-2398-8571"]},"institutions":[{"id":"https://openalex.org/I4210116985","display_name":"Sakarya E\u011fitim ve Ara\u015ft\u0131rma Hastanesi","ror":"https://ror.org/02h67ht97","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I103703290","https://openalex.org/I4210116985"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u0130rem T\u00fcrko\u011flu Kuzu","raw_affiliation_strings":["Sakarya Training and Research Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sakarya Training and Research Hospital","institution_ids":["https://openalex.org/I4210116985"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005432422","display_name":"Mehmet Fatih Orhan","orcid":"https://orcid.org/0000-0001-8081-6760","observed_orcids":["https://orcid.org/0000-0001-8081-6760"]},"institutions":[{"id":"https://openalex.org/I103703290","display_name":"Sakarya University","ror":"https://ror.org/04ttnw109","country_code":"TR","type":"education","lineage":["https://openalex.org/I103703290"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mehmet Fatih Orhan","raw_affiliation_strings":["Sakarya University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sakarya University","institution_ids":["https://openalex.org/I103703290"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.9860000014305115},{"id":"https://openalex.org/keywords/chemotherapy-induced-peripheral-neuropathy","display_name":"chemotherapy-induced peripheral neuropathy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/motor-neuropathy","display_name":"motor neuropathy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pediatric-oncology","display_name":"pediatric oncology","score":0.6710000038146973},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7400000095367432},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/neurotoxic-chemotherapy","display_name":"neurotoxic chemotherapy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.7329999804496765},{"id":"https://openalex.org/keywords/neurological-assessment","display_name":"neurological assessment","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9068999886512756},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.7628999948501587},{"id":"https://openalex.org/C2778423431","wikidata":"https://www.wikidata.org/wiki/Q417782","display_name":"Nerve growth factor","level":3,"score":0.5415999889373779},{"id":"https://openalex.org/C2779289229","wikidata":"https://www.wikidata.org/wiki/Q17153857","display_name":"Chemotherapy-induced peripheral neuropathy","level":4,"score":0.5169000029563904},{"id":"https://openalex.org/C2780168130","wikidata":"https://www.wikidata.org/wiki/Q2916167","display_name":"Neurological examination","level":2,"score":0.46650001406669617},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.4366999864578247},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.42969998717308044},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4083000123500824},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4007999897003174},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3815000057220459},{"id":"https://openalex.org/C2777096885","wikidata":"https://www.wikidata.org/wiki/Q220925","display_name":"Vinca","level":2,"score":0.3693000078201294},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.3682999908924103},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.3619999885559082},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35569998621940613},{"id":"https://openalex.org/C2780923182","wikidata":"https://www.wikidata.org/wiki/Q6135922","display_name":"Sural nerve","level":2,"score":0.3334999978542328},{"id":"https://openalex.org/C151032500","wikidata":"https://www.wikidata.org/wiki/Q5194182","display_name":"Cumulative dose","level":2,"score":0.32350000739097595},{"id":"https://openalex.org/C4661277","wikidata":"https://www.wikidata.org/wiki/Q1054157","display_name":"Cog","level":2,"score":0.31209999322891235},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.30959999561309814},{"id":"https://openalex.org/C527108885","wikidata":"https://www.wikidata.org/wiki/Q835153","display_name":"Physical examination","level":2,"score":0.3073999881744385},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.30640000104904175},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C2780130745","wikidata":"https://www.wikidata.org/wiki/Q1650750","display_name":"Neuropathology","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C2778796999","wikidata":"https://www.wikidata.org/wiki/Q643638","display_name":"Shahid","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2554999887943268}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-11399490/v1","doi":"https://doi.org/10.21203/rs.3.rs-11399490/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11399490/v1","pdf_url":"https://www.researchsquare.com/article/rs-11399490/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-11399490/v1","doi":"https://doi.org/10.21203/rs.3.rs-11399490/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11399490/v1","pdf_url":"https://www.researchsquare.com/article/rs-11399490/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322660","display_name":"Sakarya \u00dcniversitesi","ror":"https://ror.org/04ttnw109"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225340246.pdf","grobid_xml":"https://content.openalex.org/works/W7225340246.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2053241845","https://openalex.org/W2101578640","https://openalex.org/W2126550106","https://openalex.org/W2141414884","https://openalex.org/W2142721082","https://openalex.org/W2275737843","https://openalex.org/W2519767866","https://openalex.org/W2604219873","https://openalex.org/W2746890116","https://openalex.org/W2888899894","https://openalex.org/W3013503990","https://openalex.org/W3043680095","https://openalex.org/W3128646645"],"related_works":["https://openalex.org/W4288987727","https://openalex.org/W2790488598","https://openalex.org/W4408275105","https://openalex.org/W2807777452","https://openalex.org/W4391817722","https://openalex.org/W3081830231","https://openalex.org/W4386097472","https://openalex.org/W7212419684","https://openalex.org/W7164169833","https://openalex.org/W2811363161"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"No":[2],"circulating":[3],"biomarker":[4],"identifies":[5],"children":[6,30,100,109,153,184,225],"at":[7,36,63,130],"risk":[8],"of":[9,115,121,236,247],"chemotherapy-induced":[10],"peripheral":[11],"neuropathy":[12,105,141,155,165,207,228],"before":[13,50],"symptoms":[14],"appear.":[15],"We":[16],"examined":[17],"whether":[18],"serum":[19],"nerve":[20],"growth":[21],"factor":[22],"(NGF)":[23],"predicts":[24],"incident":[25],"motor":[26,206,227],"neuropathy.":[27],"Methods":[28],"Twenty-eight":[29],"starting":[31],"vincristine,":[32],"cisplatin":[33],"or":[34],"carboplatin":[35],"one":[37],"tertiary":[38],"pediatric":[39],"center":[40],"were":[41,67],"enrolled":[42],"prospectively.":[43],"Serum":[44,123,201],"NGF":[45,124,146,202],"was":[46,94,172],"measured":[47],"by":[48,69,75,83,88,230],"ELISA":[49],"the":[51,80,150,169,215,245],"course":[52],"and":[53,57,77,86,137,193,208],"on":[54,189],"days":[55],"7":[56],"30,":[58],"with":[59,164],"standardized":[60],"neurological":[61,242],"examination":[62,232],"each":[64],"point.":[65],"Groups":[66],"compared":[68],"Mann\u2013Whitney":[70],"U":[71],"test,":[72],"within-patient":[73],"change":[74],"Friedman":[76],"Wilcoxon":[78],"tests,":[79],"group-by-time":[81,170],"interaction":[82,171],"mixed-effects":[84],"modelling,":[85],"discrimination":[87],"ROC":[89],"analysis.":[90],"Results":[91],"Median":[92],"age":[93],"4.6":[95],"years":[96],"(range":[97],"2.0\u201316.9);":[98],"24":[99],"(85.7%)":[101],"received":[102],"vincristine.":[103],"Motor":[104],"developed":[106,226],"in":[107,119,152,162,182,222],"8":[108],"(28.6%,":[110],"95%":[111],"CI":[112],"15.3\u201347.1;":[113],"33.3%":[114],"vincristine":[116,180],"recipients),":[117],"resolving":[118],"seven":[120],"eight.":[122],"did":[125,138,194,203],"not":[126,139,161,173,195,204],"differ":[127],"between":[128],"groups":[129],"any":[131],"time":[132],"point":[133],"(p":[134,166,175,185],"=":[135,158,167,176,186],"0.218\u20130.611)":[136],"discriminate":[140],"(all":[142],"AUC":[143],"\u2264":[144],"0.66).":[145],"rose":[147],"significantly":[148],"across":[149],"month":[151,235],"without":[154],"(Friedman":[156],"p":[157],"0.024)":[159],"but":[160],"those":[163],"0.417);":[168],"significant":[174],"0.160).":[177],"Lower":[178],"cumulative":[179],"dose":[181],"affected":[183],"0.040)":[187],"depended":[188],"a":[190,213,234,237],"single":[191,238],"outlier":[192],"survive":[196],"correction":[197],"for":[198],"multiplicity.":[199],"Conclusion":[200],"predict":[205],"cannot":[209],"be":[210],"recommended":[211],"as":[212],"biomarker;":[214],"trajectory":[216],"divergence":[217],"is":[218],"hypothesis-generating":[219],"only.":[220],"One":[221],"three":[223],"vincristine-treated":[224],"detectable":[229],"bedside":[231],"within":[233],"course,":[239],"supporting":[240],"systematic":[241],"assessment":[243],"from":[244],"outset":[246],"vinca":[248],"alkaloid":[249],"therapy.":[250]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-06T00:00:00"}